Prime Medicine (PRME) Receivables - Net (2024 - 2025)
Prime Medicine (PRME) has disclosed Receivables - Net for 2 consecutive years, with $4.6 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Receivables - Net rose 185.02% year-over-year to $4.6 million, compared with a TTM value of $4.6 million through Dec 2025, up 185.02%, and an annual FY2025 reading of $4.6 million, up 185.02% over the prior year.
- Receivables - Net was $4.6 million for Q4 2025 at Prime Medicine, up from $120000.0 in the prior quarter.
- Across five years, Receivables - Net topped out at $55.0 million in Q3 2024 and bottomed at $17000.0 in Q1 2025.